BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7873064)

  • 1. Immunoregulation in allergy: the potential of anti-IgE antibodies of IL-4 antagonists for the treatment of allergic diseases.
    Heusser C
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):283-9; discussion 289-91. PubMed ID: 7873064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the human IgE response.
    de Vries JE; Yssel H
    Eur Respir J Suppl; 1996 Aug; 22():58s-62s. PubMed ID: 8871045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of IL-4 in persistent IgE formation.
    Savelkoul HF; van Ommen R
    Eur Respir J Suppl; 1996 Aug; 22():67s-71s. PubMed ID: 8871047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposing the mast cell: its novel integrated role in allergy.
    Polosa R; Crimi N
    Ann Ital Med Int; 1998; 13(2):78-80. PubMed ID: 9734139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune response and pathophysiology of the allergic reaction].
    Heusser CH; Brinkmann V
    Ther Umsch; 1994 Jan; 51(1):14-8. PubMed ID: 8146808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
    Chang TW; Wu PC; Hsu CL; Hung AF
    Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rethinking Th2 antibody responses and allergic sensitization.
    Stern D; Eder W; Tebow G; Lohman IC; Soprana E; Braun-Fahrländer C; Riedler J; Nowak D; Von Mutiust E; Halonen M; Vercelli D;
    Novartis Found Symp; 2004; 257():25-37; discussion 37-50, 276-85. PubMed ID: 15025390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin G4: an odd antibody.
    Aalberse RC; Stapel SO; Schuurman J; Rispens T
    Clin Exp Allergy; 2009 Apr; 39(4):469-77. PubMed ID: 19222496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-IgE--a new treatment for allergic diseases].
    Berkun Y; Shalit M
    Harefuah; 2002 Mar; 141(3):260-2, 314. PubMed ID: 11944220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells.
    Pawankar R; Okuda M; Yssel H; Okumura K; Ra C
    J Clin Invest; 1997 Apr; 99(7):1492-9. PubMed ID: 9119992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
    Yoshimoto T; Min B; Sugimoto T; Hayashi N; Ishikawa Y; Sasaki Y; Hata H; Takeda K; Okumura K; Van Kaer L; Paul WE; Nakanishi K
    J Exp Med; 2003 Apr; 197(8):997-1005. PubMed ID: 12695491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo.
    Grunewald SM; Werthmann A; Schnarr B; Klein CE; Bröcker EB; Mohrs M; Brombacher F; Sebald W; Duschl A
    J Immunol; 1998 Apr; 160(8):4004-9. PubMed ID: 9558109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse.
    Takeshita K; Yamasaki T; Akira S; Gantner F; Bacon KB
    Int Immunol; 2004 May; 16(5):685-95. PubMed ID: 15096484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
    Chen L; Overbergh L; Mathieu C; Chan LS
    Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4-dependent induction of IgE basophils in peripheral blood and IgE B cells in spleen as respective indicators of allergen sensitization and a precursor of cells secreting allergen-specific IgE antibody.
    Miyoshi-Higashino M; Hirano M; Ogita-Nakanishi H; Yamamoto-Kimoto Y; Sakurai K; Tashiro-Yamaji J; Nomi H; Takahashi T; Miura-Takeda S; Takenaka H; Kubota T; Yoshida R
    Microbiol Immunol; 2009 Jan; 53(1):30-40. PubMed ID: 19161555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation.
    Würtzen PA; Lund G; Lund K; Arvidsson M; Rak S; Ipsen H
    Clin Exp Allergy; 2008 Aug; 38(8):1290-301. PubMed ID: 18510696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polynuclear basophils, the key to allergic reactions. Modulations by chemokines].
    Devouassoux G
    Rev Mal Respir; 2000 Jun; 17(3):629-40. PubMed ID: 10951958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulation of IgE synthesis].
    Kraft D
    Wien Klin Wochenschr; 1993; 105(23):669-71. PubMed ID: 8310698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of long-term IgE antibody production by gene gun-mediated DNA vaccination.
    Ludwig-Portugall I; Montermann E; Kremer A; Reske-Kunz AB; Sudowe S
    J Allergy Clin Immunol; 2004 Oct; 114(4):951-7. PubMed ID: 15480341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.